Lack of clinically significant cardiac dysfunction during intermediate dobutamine doses in long-term childhood cancer survivors exposed to anthracyclines.

Lanzarini L, Bossi G, Laudisa ML, Klersy C, Aricò M

Open source

DOI
10.1067/mhj.2000.108237
Published
2000 Aug
Container
American heart journal
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1067/mhj.2000.108237,
  title = {Lack of clinically significant cardiac dysfunction during intermediate dobutamine doses in long-term childhood cancer survivors exposed to anthracyclines.},
  author = {Lanzarini L and Bossi G and Laudisa ML and Klersy C and Aricò M},
  year = {2000},
  journal = {American heart journal},
  doi = {10.1067/mhj.2000.108237},
  url = {https://doi.org/10.1067/mhj.2000.108237}
}

RIS

TY  - JOUR
TI  - Lack of clinically significant cardiac dysfunction during intermediate dobutamine doses in long-term childhood cancer survivors exposed to anthracyclines.
AU  - Lanzarini L
AU  - Bossi G
AU  - Laudisa ML
AU  - Klersy C
AU  - Aricò M
PY  - 2000
JO  - American heart journal
DO  - 10.1067/mhj.2000.108237
UR  - https://doi.org/10.1067/mhj.2000.108237
ER  - 

APA

L, L., G, B., ML, L., C, K., & M, A. (2000). Lack of clinically significant cardiac dysfunction during intermediate dobutamine doses in long-term childhood cancer survivors exposed to anthracyclines.. American heart journal. https://doi.org/10.1067/mhj.2000.108237

Source records